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Abstract In a controlled trial to evaluate the effective-
ness of a simple educational and physical program
administered to a large cohort of public servants, we pre-
viously found that 6 months following treatment the
monthly frequency of headache and neck and shoulder pain
and drug intake was reduced by 40% in the experimental
compared with controls. These results were stable at a
12-month follow up. The program consists of brief shoul-
der and neck exercises to be performed several times a day,
a relaxation exercise, and instructions on how to reduce
parafunction and hyperfunction of the craniofacial and
neck muscles during the day. The purpose of this work was
to investigate whether the data previously obtained could
be confirmed also in the group of 192 subjects that served
as controls in first phase of the study and received the
intervention in the second phase of the study. The primary
endpoint was the change in frequency of headache and
neck and shoulder pain expressed as the number of days
per month with pain, and as the proportion of subjects with
a C50% reduction of frequency (responder rate) at the last
2 months of the 6-month intervention period compared to
the 2 months preceding the intervention (baseline). The
number of days of analgesic drug consumption was also
recorded. Days per month with headache at the baseline
and at the end of intervention period were 6.40 and 4.58
(mean change -1.81, p \ 0.0001), respectively; days with
neck and shoulder pain were 7.48 and 6.18 (mean change
-1.30, p = 0.0179); days of analgesic consumption were
1.67 and 1.17 (mean change -0.50, p = 0.0222). The
responder rate was 42.3% for headache, 42% for neck and
shoulder pain and 58.3% for drug consumption. In con-
clusion, this study adds further evidence on the efficacy of
our program and its high acceptability in a large, unse-
lected, working population.
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Introduction
Several studies have assessed the efficacy of noninvasive
physical management in reducing the frequency of differ-
ent types of headache and neck pain. However, the weight
of the evidence is still limited and the results of recent
studies are conflicting and often limited by relatively short
follow-up periods [1–9]. In a controlled trial to evaluate the
effectiveness of a simple educational and physical program
administered to a large cohort of public servants, we found
that 6 months following treatment the monthly frequency
of headache and neck and shoulder pain was reduced by
40% in the experimental compared with controls. More-
over, the index of headache or neck and shoulder pain, as
well as the frequency of drug intake, was significantly
decreased in the treatment group [10]. These results were
stable at a 12-month follow up [11].
The purpose of this work was to investigate whether the
data previously obtained could be observed also in the
group of subjects that served as controls in the first phase of
the study and received the intervention subsequently.
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Methods
The study design of the entire trial according to time flow is
reported in Fig. 1. The trial was conducted from March
2005 (month 1) to April 2006 (month 14) and included two
phases [10]: during the first phase, an intervention con-
sisting of a physical and educational program was admin-
istered to Group 1, while Group 2 served as control. In the
second phase, the same intervention was administered to
Group 2. Both Groups were followed up to the end of the
trial (month 14).
Eligible participants to this study were 192 employees
(Group 2) at the peripheral registry offices and the tax
office of the City of Turin’s registry who belonged to the
control group in the first phase of our trial [10].
After informed consent all participants were given a
diary for the day-by-day recording of severity (score 0–5)
and duration (hours) in that day of their headache and neck
and shoulder pain, intake of analgesics (by type) and
menstruation days. Diaries were personally distributed and
collected each month by the staff or by office members
designated as supervisor. Each time particular importance
was given to the importance of filling out the diaries during
the time period. Diaries were directly filled in by subjects
and were automatically processed by an optic reader via a
dedicated computer program. Detailed data relative to
headache and neck and shoulder pain were collected in a
standardized fashion; a psychological assessment accord-
ing to Axis 1 of the DSM-IV was carried out [12], and a
clinical examination that included palpation of pericranial
and cervical muscles was performed.
The following diagnoses were made according to the
guidelines of the International Classification of Headache
Disorders [13] and the International Association for the
Study of Pain [14]: migraine with or without aura (M),
tension type headache (TTH), myogenous neck and
shoulder pain (MP). Two or more diagnoses in the same
subject were possible.
In the first phase of the trial the subjects in Group 2 were
asked to keep the diaries for 8 months without receiving
instructions. However, they were encouraged by reminding
each month that after some time they would also receive
the program. At the beginning of month 9, the same
intervention as in the previous study [10] was then applied.
The program consists of brief shoulder and neck exer-
cises to be performed several times a day, a relaxation
exercise, and instructions on how to reduce parafunction
and hyperfunction of the craniofacial and neck muscles
during the day. Particular importance was given to the
purpose of reducing muscle contraction and to increase the
capability of perceiving it when too elevated.
The instructions were as follows
Relaxation exercise (once or twice a day): Sit down in a
comfortable armchair in a quiet room. Let your lower
jaw drop completely for about 10–15 min. Apply warm
pads on your cheeks and shoulders.
Posture exercises: 8–10 times every 2–3 h: (1) Stand
upright with your heels, hips, and nape of the neck
against a wall. Without moving the rest of your body,
bring your shoulders into contact with the wall and
release, rhythmically. (2) With your body and head
against the wall, make horizontal movements of the
head, forwards and backwards. (3) Cup your hands
behind your neck. Stretch your head backwards against


















Fig. 1 The design of the entire
trial according to time flow.
Group 2 was the control group
in phase 1 (months 1–8) and the
study group in phase 2 (months
7–14)
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Visual feedback: Place red labels in strategic sites to
remind you to avoid excessive contraction of your head
and neck muscles.
The instructions were given by the members of the
health staff. The program was explained to groups of 30–40
subjects with the help of a short film followed by a prac-
tical demonstration and training. The time employed ran-
ged from 45 to 60 min. Red labels were placed on the
workplace. Other labels were provided for use at home.
A written form was also provided with illustrations on the
exercises and the relative instructions. After 2 and
4 months, the instructions were reiterated by the same
clinicians at the workplace. Participants continued to fill in
their diaries for 6 months after the beginning of the inter-
vention. No indications for a pharmacological treatment
were given.
The study was conducted in accordance with the Dec-
laration of Helsinki and the Guidelines for Good Clinical
Practice. The protocol was assessed and approved by the
Institutional Review Board of the San Giovanni Battista
Hospital of the City of Torino. All eligible subjects were
asked to provide their informed consent.
Study outcomes
The primary outcome measurement of the study was the
frequency of headache or of neck and shoulder pain
(number of days per month with a headache/neck and
shoulder pain) after the intervention compared with the
data of these variables at the baseline. Two endpoints were
used: (1) the frequency of pain at months 13–14 compared
to the 2 months preceding the intervention (baseline);
(2) the proportion of subjects with 4 or more days per
month with headache (neck and shoulder pain) who
achieved a C50% reduction in pain frequency by months
13–14 (responder rate).
Secondary outcome measurements were the differences
in (a) headache or neck and shoulder pain index (inten-
sity 9 frequency), where intensity is the sum of intensity
of the daily pain in a month divided by number of days
with pain; frequency is number of days with pain in a
month; (b) frequency of days with analgesic drug
consumption.
The Migraine Disability Assessment (MIDAS) ques-
tionnaire [15] was also administered at the baseline and at
the end of the intervention period. Subjects were asked to
record the number of days in the previous 3 months on
which they missed paid or household work because of their
head or neck pain. Also, they counted the number of days
during which their productivity was \50% of their normal
productivity for both paid and household work. The num-
ber of days absent from family, social or leisure activities
was also analyzed. The overall MIDAS score is the sum of
all these scores and is expressed in terms of number of
days. The reliability and internal consistency of the
MIDAS were assessed in national and international popu-
lation-based studies [15–17]. In particular, the MIDAS
items for missed days of work or school and for missed
days of household work were similar to the corresponding
diary-based estimates of missed work or school [17]. The
questionnaire’s test–retest reliability has been checked in
Italian on 109 patients and was closely similar to that found
in English-speaking patients [18].
Statistical analyses
The present study focussed on the 192 subjects included in
the Group 2 of the trial (Fig. 1); for 177 subjects diaries
were available at months 7–8 (baseline of the second phase
of the trial). The principal analysis of the present study was
performed on the population of 162 subjects with complete
diaries for the second phase of the trial, that is, from
months 7–8 (baseline) to months 13–14 (end of follow-up).
Baseline differences between subjects with complete dia-
ries and subjects with incomplete diaries were investigated
with the use of the chi-square test or Fisher’s exact test for
categorical variables and with the use the Mann–Whitney
test for continuous variables.
The changes from baseline of symptoms frequency
(headache, neck/shoulder pain) were evaluated with the
Student’s paired t-test. The same method was employed in
analyzing change from baseline of MIDAS scores.
Responder rates were calculated as the proportion of
symptomatic subjects (mean of C4 days/month of pain
during the baseline period) with a C50% reduction in
headache days and in neck and shoulder pain days at the
end of follow up (months 13–14).
As secondary analysis, we calculated the mean changes
in symptom frequency between months 13–14 and months
1–2 (that is, for the entire period of the trial) for subjects
with complete diaries included in the Group 2. Thereafter,
we compared the mean changes in the symptoms frequency
observed in Group 2 with those observed in Group 1 [11].
Due to non-randomized design of this study, mean differ-
ences were compared by ANCOVA, adjusting for age, sex,
presence of anxiety or mood disorders, frequency symp-
toms at month 1–2 of each subject, presence of neck and
shoulder pain (when the reduction in the frequency of
headache and in the use of drug consumption was ana-
lyzed), and presence of headache (when the reduction in
the frequency of neck and shoulder pain and in the use of
drug consumption was analyzed).
Finally, the reduction of the frequency of pain and
drug consumption was evaluated by applying longitudi-
nal models to the Group 2 intention-to-treat population
J Headache Pain (2010) 11:409–415 411
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(n = 192), including in the analysis also the data available
at each time point for subjects with incomplete diaries,
without carrying forward the last value observed. The
intention-to-treat analysis using a longitudinal approach
allows evaluating the time course of the effect of the
intervention during the whole period of the trial. The daily
probability of a headache episode during the follow-up was
analyzed using a logistic regression model, adjusted for
clustering due to repeated measures on the same subject,
with the Huber–White sandwich estimators [19]. For all the
endpoints studied the effect of time during the follow-up
was modeled using a restricted cubic spline function, to
allow for potential non-linear trends.
Analyses were performed using STATA 9.2 (STATA
Corp., College Station, TX, USA), S-Plus 6.2 (Insightful
Corp., Seattle, WA, USA) and with Design and Hmisc
program libraries 2 [20].
Results
Table 1 summarizes the characteristics at the baseline
(months 7–8) of subjects included in the principal analysis
of the present study, separately for those with complete
(n = 162) and incomplete (n = 15) diaries up to the end of
the follow up (months 13–14). No statistically significant
differences were found between the groups. However,
among subjects with incomplete diaries the prevalence of
those with at least 4 days/month with headache, neck or
shoulder pain, and consumption of analgesic drugs was
higher compared to those with complete diaries. On the
other hand, among the 15 subjects with incomplete diaries,
5 reported no headache and 8 reported no neck pain during
the last month of recording.
The effects of the intervention for the different end-point
examined are summarized in Table 2. For all the endpoints,
there was a significant improvement after the intervention.
Mean days per month with headache were 6.40 and 4.58
at the baseline and at the end of follow up respec-
tively, with an absolute reduction of -1.81 (95% CI -2.54,
-1.09; p \ 0.0001). Mean days with neck and shoulder
pain were 7.48 and 6.18, respectively (absolute reduction
-1.30, 95% CI -2.38, -0.23; p = 0.0179); mean days
of analgesic consumption were 1.67 and 1.17, respec-
tively, with a reduction of -0.5 (95% CI -0.93, -0.07;
p = 0.0222).
Subgroup analysis showed the following absolute mean
reductions: -1.88 (95% CI -2.59, -1.17; p \ 0.001) for
subjects with M only; -2.05 (95% CI -4.12, 0.03;
p = 0.053) for subjects with TTH only; -3.09 (95% CI
-4.87, -1.32; p = 0.001) for subjects having M and TTH.
For all the outcomes investigated, the reduction in the
frequency was more pronounced in the subgroups of sub-
jects with a higher prevalence of disorders at the baseline.
Table 3 shows the proportion of subjects with 4 or more
days/month with pain (or drug consumption) during the
baseline period who reported a C50% decrease or increase
in frequency at 6 months. Improved subjects were 42.5%





p Total (n = 177)
Age, median (IQ range) 44.0 (35;49) 45.0 (34.5;54.5) 0.549 44 (35–49)
Females 138 (85.2%) 11 (73.3%) 149 (84.2%)
Migraine with or without aura (M)a, without TTH 53 (32.7%) 4 (26.7%) 0.777 57 (32.2%)
Tension type headache (TTH)a, without M 41 (25.3%) 5 (33.3%) 0.343 46 (26.0%)
Migraine and TTH 37 (22.8%) 3 (20.0%) 0.548 40 (22.6%)
Myogenous neck and shoulder pain (MP)a 124 (76.5%) 12 (80.0%) 0.761 136 (76.8%)
M or TTH, without MP 23 (14.20%) 1 (6.67%) 0.580 24 (13.6%)
MP, without M or TTH 16 (9.88%) 1 (6.67%) 0.565 17 (9.6%)
M or TTH, and MP 108 (66.7%) 11 (73.3%) 0.599 119 (67.2%)
Subjects with at least 4 days/monthb with:
Headache 73 (45.1%) 9 (60.0%) 0.267 82 (46.3%)
Neck or shoulder pain 69 (42.6%) 9 (60.0%) 0.194 78 (44.1%)
Consumption of analgesic drugs 24 (14.8%) 3 (20.0%) 0.705 27 (15.3%)
GAD and/or Depression (at month 8) 49 (30.2%) 7 (46.7%) 0.191 56 (31.6%)
Data are presented overall and separately for subjects with and without complete diaries for all months; data are number (%) if not otherwise
indicated
a Diagnosis based on the clinical examination and the diaries at baseline
b Mean monthly frequency during the baseline
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for headache, 42% for neck and shoulder pain and 58.3%
for drug consumption).
Table 4 reports the data of the MIDAS questionnaire.
An improvement in all the parameters was observed after
the intervention, although for the total MIDAS score the
difference was not statistically significant.
In a secondary analysis we compared the effect of the
intervention during the whole trial period (from months
1–2 to months 13–14) between the two study groups
(Group 1 and Group 2). This analysis was based on sub-
jects for whom complete diaries were available for the
entire period: n = 156 in Group 1 [11] and n = 160 in
Group 2. In Group 1 (that is, in the group of subjects that
received the intervention during the first phase of the study
and was then followed up to month 14), we observed a
mean absolute reduction of -2.39 days per month with
headache, as previously published [11]. In Group 2, the
mean reduction was -1.71 days per month with headache.
The adjusted between-groups difference (1.05) was not
significant (p = 0.093). Comparable figures were observed
for the other main endpoints: the adjusted between group
difference was 1.38 for days with neck/shoulder pain and
0.22 for days with analgesic drug consumption; both these
differences were not statistically significant.
Figure 2 shows the results observed with the logistic
regression model based on the Group 2 intention to treat










Days with headache (mean) 6.4 (8.14) 4.58 (7.64) -1.81 (-2.54, -1.09) \0.0001
Among subjects with at least 4 days/month with headache
at baseline
12.49 (8.81) 8.62 (9.65) -3.87 (-5.20, -2.54) \0.0001
Headache Index (F 9 I) 0.45 (0.74) 0.32 (0.67) -0.13 (-0.19, -0.07) 0.0001
Among subjects with at least 4 days/month with headache
at baseline
0.89 (0.92) 0.60 (0.87) -0.29 (-0.40, -0.18) \0.0001
Neck/shoulder pain
Days with neck/shoulder pain (mean) 7.48 (10.28) 6.18 (9.96) -1.30 (-2.38, -0.23) 0.0179
Among subjects with at least 4 days/month with neck/shoulder
pain at baseline
16.7 (9.88) 12.8 (11.39) -3.93 (-5.99, -1.88) 0.0003
Neck/shoulder pain Index (F 9 I) 0.46 (0.78) 0.39 (0.79) -0.07 (-0.14, -0.01) 0.0280
Among subjects with at least 4 days/month with neck/shoulder
pain at baseline
1.04 (0.92) 0.84 (1.02) -0.20 (-0.34, -0.06) 0.0064
Analgesic drug consumption
Days with analgesic drug consumption (mean) 1.67 (3.85) 1.17 (3.44) -0.5 (-0.93, -0.07) 0.0222
Among subjects with at least 4 days/month with analgesic drug
consumption at baseline
8.56 (6.42) 5.12 (7.53) -3.44 (-6.01, -0.86) 0.0111
Results are based on the subjects for whom diaries for all months (7th to 14th) were available
Table 3 Proportion of subjects with 4 or more days/month with pain (or drug consumption) during the baseline period that had a reduction
(Improved) or an increase (Worsened) in pain frequency or drug consumption of 50% or more at the end of follow-up
n (%) 95% CI
Headache (subjects with at least 4 days/month with headache, n = 73)
Improved 31 (42.3) 30.9–54.6
Worsened 3 (4.11) 0.9–11.5
Neck/shoulder pain (subjects with at least 4 days/month with neck/shoulder pain, n = 69)
Improved 29 (42.0) 30.2–54.5
Worsened 7 (10.1) 4.2–19.8
Analgesic drug consumption (subjects with at least 4 days/month with drug consumption, n = 24)
Improved 14 (58.3) 36.6–77.9
Worsened 1 (4.17) 0.1–21.1
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population (n = 192) during the whole study period of the
trial (from months 1 to 14). In the first phase of the trial
(months 1–8) data for Group 2 were somewhat fluctuating.
One reason may be related to the subjects’ expectancy,
reinforced by keeping a diary. Moreover, a seasonal effect
was particularly evident in July–August, when in Italy the
climate is warm. The fact that most workers take their
holidays in this period may be particularly relevant [10].
However, at the end of the first phase the data tended to the
initial values while in the second phase of the trial the
improvement was constant along the whole period.
Discussion
In the control arm of a large non-randomized controlled
trial we examined the efficacy of a physical and educa-
tional program in reducing headache and neck and shoulder
pain. The purpose of this work, that represents a secondary
outcome of the trial protocol, was to investigate whether
the results previously obtained [10, 11] could be confirmed
also in the group of subjects that served as controls in the
first phase of the study and received the intervention
subsequently.
The present data reinforce the evidence of the efficacy
of the educational and exercise programme applied. In this
group we observed a significant reduction in the frequency
of headache and neck and shoulder pain, as well as in the
frequency of drug consumption, at the end of the trial
compared with the 2 months baseline. The benefit of the
intervention was observed also using different analytical
approaches.





Change between month 14
and month 8 (mean, 95% CI)
p
On how many days in the last 3 months did you miss
work or school because your headaches?
0.60 (2.92) 0.43 (1.89) -0.16 (-0.60, 0.28) 0.4719
How many days in the last 3 months was your
productivity at work or school reduced
by half or more because of your headaches?
(Do not include days you counted in question 1
where you missed work or school)
2.52 (6.01) 1.53 (5.71) -0.99 (-2.09, 0.11) 0.0776
On how many days in the last 3 months did you not
do household work because of your headaches?
1.99 (4.91) 1.51 (5.94) -0.48 (-1.52, 0.56) 0.3649
How many days in the last 3 months was your productivity
in household work reduced by half of more because
of your headaches? (Do not include days you counted
in question 3 where you did not do household work)
2.70 (6.91) 1.47 (4.01) -1.23 (-2.38, -0.08) 0.0369
On how many days in the last 3 months did you miss family,
social or leisure activities because of your headaches?
1.66 (4.85) 1.12 (5.62) -0.54 (-1.66, 0.58) 0.3402
MIDAS total score 9.47 (19.54) 6.07 (19.54) -3.40 (-6.83, 0.03) 0.0523
Fig. 2 Reduction in pain frequency and drug consumption during the
entire trial period in the Group 2 intention-to-treat population. Results
are presented as estimated daily probabilities. The dashed lines
indicate the 95% CI
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The data from the previous studies [10, 11] were
somewhat better, although not statistically so. The slightly
lower benefit observed in the present study may be prob-
ably attributed to a seasonal effect. In the previous study
the intervention was performed in a warmer period (May–
October) during which most workers take their holidays as
opposed to this study (November–April). Another reason
may be the different characteristics of work place and
activity of the subjects. Working in a peripheral registry
office and in the tax office may indeed be somewhat more
stressful than working in the central registry office where,
inter alia, there is a more frequent workplace turnover.
Nevertheless, the data show that the program is efficacious
also in different working conditions.
As mentioned in the previous papers [10, 11], some
features of our program are different from the other inter-
ventions: in particular, the fact that it may be applied at the
workplace may favor a reciprocal reinforcement between
the participating subjects. Indeed, when the program was
administered, the participants were encouraged to remind
each other of keeping the muscle relaxed while working
and to perform the exercises together. Such peculiar
characteristics may partly explain our better results, com-
pared with some other trials [21, 22].
In conclusion, the moderate but consistent benefit
observed in the present study strengthens the evidence of
the efficacy of our program and its high acceptability in a
large, unselected, working population.
A study with a randomized design on a much higher
number of subjects is now in progress in order to confirm
that this program can be regarded as an effective way of
reducing head and neck pain and analgesic drug con-
sumption in extensive working communities.
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